Astellas Pharma Inc. · TSE:4503
Astellas Pharma — Investor Presentation (June 2021)
15 slides from Astellas Pharma's investor presentation, Jun 30, 2021
Slide 1: Corporate Strategic Plan 2021
J «Bons 2020FE SE#ROME #2512018 (CSP2018) OMRYIBY $EF5tiH 2021 (CSP2021) OME Wrastellas
Slide 2: ] san
] san 2 COBPICHME 1 Tl SHRED Sti, PAR, BER. REICH TS SscME LO EOWOMAOBRCA Mlk, PATOAZARROR PS ICHMT SERO RL CT. CNSOMMECRESBOREAFRURCHRICBO< ABU YD BEICKStOCHY, BMBLOURHOU AD CREE CBREEACWET. BRA BAI KOT. CHSORRO Rik LICRROMRRCAS< BSAA HYVES. CTOLZWACUTA. (i) BH wyICHISSRRROBILHSLVU RR ARAIOCUIE. (i
Slide 3: Corporate Strategic Plan 2018 and 2021
J «Bons 3 2020 BeRAORE #2512018 (CSP2018) OMRYIBY $EF5tiH 2021 (CSP2021) OME Wrastellas
Slide 4: Financial results (APN-2)
I ee (APN-2) 4 ia IRUAPEBIER | sotatransehaiae =a Eb Mm # 12,495 -513 -3.9% 35_b A ii 2,461 -307 -11.1% ab 8 Ha 10,035 -206 -2.0% ait 5,043 +50 +1.0% Att 2 BH AG Et 2,245 43 +0.1% sear tr 2,514 -264 -9.5% 37 34 HAF a 2,099 -133 -5.9% Wastellas
Slide 5: Financial results (DVA-2)
] ei (DVA-2) 5 =a IRUAPEBIER | sotatransehaiae cs FC Mm 12,495 -513 -3.9% B® FH 1,361 -1,079 -44.2% Hi Sl ay Fl a 1,453 -1,000 -40.8% 5 HF 1,206 -748 -38.3% Wastellas
Slide 6: Corporate Strategic Plan 2018 and 2021
J «Bons 6 2020 BRRAORE #2512018 (CSP2018) OMRYIBY #2252021 (CSP2021) OME Wrastellas
Slide 7: CSP2018 review
| 25201 8mRUiE (HN) 7 @ FF=E1H201 SO3 TOR REAORY MAMSHECSH Y INRA CHER Tee ee mOscLisialcHAL. ESI ee emldsS< OBSSRRZEM TTC we HEICABMLEAP TT NEUST 4 Shee guetta Primary FocushiOAKheeAY TE BORMCON—KFUYUTICRI Reet EMOPSOPS AMS blcalt CER Hh! Wrastellas
Slide 8: CSP2018 review (results)
] 25201 8iRU3RY (tN) 8 @ 35 CH mimmitAs < Sib. EB MB MOTLMAS < HR @ 3h OaRscHARm r PERSE BICLSEV IF AOREISHRKT @ SANS AREA (fF) 14,000 12,000 10,000 8,000 6,000 4,000 2,000 ¢) 20184 ERK EAA HO EDO LIAO 2019F ER Pr A eee mB eOth ge JO7579 gSDN7Oy arson gm XTANDI 20208 ERK “Wrastellas | me GaescHi ial
Slide 9: Corporate Strategic Plan 2018 and 2021
J «Bons 9 2020 BRRAORE #2512018 (CSP2018) OiRYIBY) $EF5tiH 2021 (CSP2021) OME Wrastellas
Slide 10: VISION
| 218202108 i 225182018 2582021 VISION ELEM. AROSE. ERSG|THC TRIN. VISIONZRA DHSS SAURE {fi {6 OFGER By OS El Sora (bog aca {iii = PILALERKRTSEDIE MWATPYZT LRABTS AZk AYR Bie Wastellas
Slide 11: Primary Focus approach
] ese " vepgainl PRHANOMERAHS|S SBI Ron’ OMe BEE AOEVBW PO KNLOSA Pes Annem ePrimary Focus S2aheneeyo7o ree Ae SO OL ORAA MED RIED pee SELN BEE PICMMOTOI TI hOB Rx+ EYAZOER WE OE EERO? Ie ABLc Mmm eBaT— eae teetis VL CHAE Wrastellas * VANZ®, PADCEV®, LNVYY®, fezolinetant, WUNYFUVI, AT132
Slide 12: VISION
| 218202108 7 225182018 2582021 VISION ELEM. AROSE. ERSG|THC TRIN. VISIONZRA DHSS SAURE {fi {6 OFGER By OS El Sora (bog aca {iii = PILALERKRTSEDIE MWATPYZT LRABTS AZk AYR Bie Wastellas
Slide 13: Targets through 2025
| RRA "7 1. Se bust > XTANDISLOB RB Ron* OseLlié 2025#E1C139b2,000H AWE 2.N4 F547 Vitis : Focus AreeavOUrIAkDSO sLIF2Z030FEIC 5,0008RTRWE 3.17 BRS : 20257 EIC30%WE KMRAREEKTOCCC 2025FE lcs TEA LT * VANZ®, PADCEV®, LNVYY®, fezolinetant, WUNYFUVI, AT132
Slide 14: I meat
I meat © KRERRT SLOOBRKA SRB © tlm APSHRORRICROS, ESHA 5B UCC KEOS|S LIT o RARE SH SHEME FRIES Bex 100 (FA) mmm ic 80 4. 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 FUBRIA, BORE a eC IP RACROHE Tie . 7 + 5,000 4,000 x ° ° . ° ° . * ° eS eS r 3,
Slide 15: Bits SEBOR GN
Bits SEBOR GN D Pelee